20th International Conference on Pharmaceutical Drug Design and Adverse Effect

From Verify.Wiki
Jump to: navigation, search
Wizard photo 20th International Conference on Pharmaceutical Drug Design and Adverse Effect 1.jpg
20th International Conference on Pharmaceutical Drug Design and Adverse Effect
Date November 19 - 20, 2018
Place Havana, Cuba

The ICPDDAF 2018:( 20th International Conference on Pharmaceutical Drug Design and Adverse Effect) aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmaceutical Drug Design and Adverse Effect. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmaceutical Drug Design and Adverse Effect.[1]

Top Photos

Conference Program

ICPDDAF 2018 has teamed up with the Special Journal Issue on Pharmaceutical Drug Development and Adverse Effects.

We solicit your gracious presence at the upcoming 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety scheduled to happen during July 17-18, 2017 in Munich, Germany focussing on the advancements in emerging research and technologies in pharmacovigilance, clinical trials and risk management.

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Theme:  “Advanced Regulatory Compliance in Pharmacovigilance Operations and Innovations”

Conference Aims and Objectives The ICPDDAF 2018: 20th International Conference on Pharmaceutical Drug Development and Adverse Effects aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmaceutical Drug Development and Adverse Effects. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmaceutical Drug Development and Adverse Effects.

Call for Contributions

All honorable authors are kindly encouraged to contribute to and help the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Pharmaceutical Drug Design and Adverse Effect are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the International Science Index (ISI), Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.

The tentative scientific programme will be released soon

Important Dates

Abstracts/Full-Text Paper Submission Deadline   December 10, 2017

Notification of Acceptance/Rejection   December 31, 2017

Final Paper (Camera Ready) Submission & Early Bird Registration Deadline   October 23, 2018

Conference Dates   November 19 - 20, 2018

Important Notes

Please ensure your submission meets WASET's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.

Please refer to the Paper Submission GUIDE before submitting your paper.


International Scientific Committee

Suleyman Akocak   Adiyaman University, TR

Arzum Erdem Gursan   Ege University, TR

Lei Mei   Agilent Technologies, US

Chun Wu   Mount Marty College, US

Ankit Gupta   University of Chicago, US

Kal Ramnarayan   Sapient Discovery, US

Xintong Wang   Vanderbilt University, US

Gwo-Yu Chuang   National Institutes of Health, US

Shashikant Srivastava   Ut Southwestern Medical Center, US

Mohan Boggara   Rensselaer Polytechnic Institute, US

Chandan Thomas   Lake Erie College of Osteopathic Medicine School of Pharmacy, US

Subeena Sood   Medstar Health Research Institute, US

Boojala Vijay B Reddy   Queens College - City University of New York, US

Zhengwu Lu   Abbott Laboratories, US

David Stiles   Medtronic, US

Ching-An Peng   Michigan Technological University, US

Sani Ismaila   Usmanu Danfodiyo University, NG

Farid Semsarha   Mim Daroo Pharmaceutical Co., IR

Gowri Meiyazhagan   Periyar University, IN

Emmanuel Oladayo Olawode   Rhodes University, ZA

Aslam Khan   King Saud Bin Abdulaziz University for Health Sciences, SA

Sajeev Babasahib   Ahalia School of Pharmacy, IN

Moulay Alaoui-Jamali   Mcgill University, CA

Rose Anne Chua   National University, PH

Yogesh Dalvi   Pushpagiri Institute of Medical Sciences and Research Centre, IN

Pedro Abreu   School of Health Sciences and Technologies of the University Lusófona, Portugal

Tasnuva Tamanna   Swinburne University of Technology, Australia

Tommaso Adamo   University of Salento, Italy

Simona Dostalova   Mendel University in Brno, Czech Republic

Merita Dauti   State University of Tetova, Macedonia

Thitaporn Thoopputra   University of Newcastle, Australia

Arpa Petchsomrit   Prince of Songkla University, Thailand

Yaowaporn Sangsen   Prince of Songkla University, Thailand

Tanvir Ahmed   Griffith University, Australia

Zhong-Ru Xie   University of Georgia,

Alaa Hamed Salama   National Resaerch Center,

Ali Saad   Ahmadi Hospital, EG

Sandeep Goyal   Baba Farid University of Health Sciences, IN

Lola Alimkhodjaeva   National Research Center of Oncology,

Ibrahim Labouta   Alexandria University, EG

Preyesh Stephen   University Laval, CA

Anton Larenkov   Burnasyan Federal Medical Biophysical Center, Russian Federation

Conference Volunteering

World Academy of Science, Engineering and Technology keenly seeks enthusiastic academicians, scholars and students who would love to contribute to the conference in the following positions:

Keynote/Invited/Plenary Speaker Eminent and outstanding scientists and researchers are kindly invited to deliver speech as Keynote/Invited/Plenary Speaker.

Conference Program Chair During the Conference Days Academicians are kindly invited to act as a Program Chair to manage and coordinate the sessions (invite and introduce the session chairs at the beginning of the sessions, provide the necessary information to the session chairs).

Conference General Chair, Publicity Chair Academicians are kindly invited to contribute, manage and promote the conference in academic circles.

Special Session / Workshop Organizer Each special session or workshop should include 5 to 10 oral & e-poster (a short electronic presentation including discussions will last in 5 min. with the oral presentations) presentations.


Benefits of being conference volunteer

* Free Conference Registration

* Certificate of contribution

* Travel and Accommodation charges are not covered.

References:

  1. https://www.waset.org/conference/2018/11/havana/ICPDDAF

Verification history